Kevin Bielamowicz

3.3k citations
30 papers · 684 indexed · h-index 12
Topics
Glioma Diagnosis and Treatment (10 papers)CAR-T cell therapy research (8 papers)Immunotherapy and Immune Responses (8 papers)

In The Last Decade

Kevin Bielamowicz

24 papers receiving 676 citations

Peers

Kevin Bielamowicz
Comparison fields: 5 of 66
  • Oncology 471
  • Biomedical Engineering 203
  • Immunology 200
  • Genetics 167
  • Molecular Biology 160
Replace Samuel Haile with:
Samuel Haile United States
Selena Lorrey United States
Shilpa Alekar United States
Jonathan Lerner United States
Simon Khagi United States
Stephanie Mgebroff United States
Khun Visith Keu United States
Carole Ramirez France
Irina V. Balyasnikova United States
Moa Fransson Sweden
Kevin Bielamowicz relative to Samuel Haile United States Samuel Haile's profile →
Citations per field
00.5×
Samuel Haile · 1×
Citations per year

Countries citing papers authored by Kevin Bielamowicz

Since Specialization
Citations

This map shows the geographic impact of Kevin Bielamowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Bielamowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Bielamowicz more than expected).

Fields of papers citing papers by Kevin Bielamowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Bielamowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Bielamowicz. The network helps show where Kevin Bielamowicz may publish in the future.

Co-authorship network of co-authors of Kevin Bielamowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Bielamowicz. A scholar is included among the top collaborators of Kevin Bielamowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Bielamowicz. Kevin Bielamowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 6
4 2
5 1
6 98
7 11
8 4
9 27
10 1
11 45
12 0
13 0
14 1
15 0
16 339
17 6
18 1
19 25
20 41

About Kevin Bielamowicz

Kevin Bielamowicz is a scholar working on Genetics, Neurology and Immunology, having authored 30 papers that have together received 684 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (471 citations), Genetics (167 citations) and Immunology (200 citations). Kevin Bielamowicz has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Nabil Ahmed, Meenakshi Hegde, Analiz Rodriguez, Malini Mukherjee, Tiara T. Byrd, Pavel Sumazin, Kristen Fousek, Sujith K. Joseph, Jordan S. Orange and Meng-Fen Wu. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026